Linda J. Van Eldik, director of the Sanders-Brown Center on Aging at the University of Kentucky, co-authored a paper reporting the first human clinical study of a drug candidate that suppresses injury and disease-induced ...
Apr 9, 2020
0
2
With their expertise in the safe and effective use of medications, pharmacists can help in the management of chronic diseases. A review and analysis published in the British Journal of Clinical Pharmacology indicates that ...
Nov 28, 2019
0
2
In an editorial published in the British Journal of Pharmacology (BJP), the Editor-in-Chief and Senior Editors have recommended that all future studies published in the journal should formally address sex as an experimental ...
Aug 23, 2019
0
3
Researchers from the University of Liverpool and Queen's University Belfast have been awarded over £1m by the Engineering and Physical Sciences Research Council (ESPRC) to examine the use of nano-engineered microarray patches ...
Aug 20, 2019
0
4
Medications currently used to treat multiple sclerosis (MS) can merely reduce relapses during the initial relapsing-remitting phase. Many patients, however, develop progressive MS at a later stage, with disability becoming ...
Aug 20, 2019
0
4
Researchers have found that severe malnutrition is associated with lower exposure to the antimalarial drug lumefantrine in children treated with artemether-lumefantrine, the most common treatment, for uncomplicated falciparum ...
Jul 24, 2019
0
0
A gene has been found by researchers to increase the risk for a severe and potentially life-threatening reaction to a commonly prescribed antibiotic—vancomycin.
Jun 11, 2019
0
2
A new series published in the British Journal of Clinical Pharmacology (BJCP) aims to help clinicians, researchers, and patients access and understand recent guidelines and regulatory documents issued by the European Medicines ...
May 30, 2018
0
2
Despite the U.S. Congress providing incentives to drug manufacturers to encourage the study of medications in children, few approved drugs include safe dosing information for obese kids.
Jan 19, 2018
0
11
(HealthDay)—For development of oncology drugs in Japan, the global trial (GT) strategy and early-initiation bridging (BG) strategy are associated with shorter submission lag (SL) than late-initiation BG strategy, according ...
Jun 21, 2017
0
1
